Effect of the preschool pertussis booster on national notifications of disease in Australia

Pediatric Infectious Disease Journal

Volumn 22, Issue 11, 2003, Pages 956-959

  Torvaldsen, Siranda ^a   McIntyre, Peter B ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Booster dose; Pertussis; Vaccine

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; CONTROLLED STUDY; EPIDEMIC; FEMALE; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; DISEASE NOTIFICATION; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; PERTUSSIS VACCINE; POPULATION SURVEILLANCE; WHOOPING COUGH;

EID: 0345708256     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000095198.75170.b6     Document Type: Article

References (25)

1. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increased reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28:1230-7.
2. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents. J Infect Dis 2000;182:1409-16.
3. Orenstein WA. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination. Clin Infect Dis 1999;28 Suppl:S147-50.
4. Therre H, Baron S. Pertussis immunisation in Europe: the situation in late 1999. Eurosurveillance 2000;5:6-10.
5. Bass JW, Wittler RR. Return of epidemic pertussis in the United States. Pediatr Infect Dis J 1994;13:343-4.
6. Halperin SA, Bortolussi R, MacLean D, Chisholm N. Persistence of pertussis in an immunized population: results of the Nova Scotia enhanced pertussis surveillance program. J Pediatr 1989;115:686-93.
7. Chief Medical Officer. Letter 2001. 〈 www.doh.gov.uk/cmo/letters/cmo0105.htm〉. Last updated: October 15, 2001. Accessed December 12, 2002.
8. Pichichero ME, Anderson EL, Rennels MR, Edwards KM, England JA. Fifth vaccination with diphtheria, tetanus and acellular pertussis is beneficial in four- to six-year-olds. Pediatr Infect Dis J 2001;20:427-33.
9. National Health and Medical Research Council. The Australian immunisation handbook. 5th ed. Canberra: Australian Government Publishing Service, 1994.
10. National Health and Medical Research Council. The Australian immunisation handbook. 7th ed. Canberra: Australian Government Publishing Service, 2000.
11. National Health and Medical Research Council. Surveillance case definitions. Canberra: Australian Government Publishing Service, 1994.
12. The SAS System for Windows [computer program]. Version 6.12. Cary, NC: SAS Institute, Inc., 1996.
13. Microsoft® Excel 97 [computer program]. Boston: INSO Corp., 1993.
14. Achat H, McIntyre P, Burgess M. Health care incentives in immunisation. Aust N Z J Public Health 1999;23:285-8.
15. Hull B, Lawrence G, MacIntrye CR, McIntyre PB. Immunisation coverage: Australia 2001. Canberra: National Centre for Immunisation Research and Surveillance, 2001.
16. O'Brien ED, Sam GA, Mead C. Methodology for measuring Australia's childhood immunisation coverage. Commun Dis Intell 1998;22:36-7.
17. Childhood immunisation coverage. Commun Dis Intell 2000; 24:324.
18. McIntyre P, Amin J, Gidding H, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998. Commun Dis Intell 2000;24(Suppl):S1-83.
19. MacIntyre CR, Nolan T. Attitudes of Victorian vaccine providers to pertussis vaccine. Med J Aust 1994;161:295-9.
20. Australian Bureau of Statistics. 1989 National Health Survey. Children's Immunisation, Australia. Canberra: Australian Government Publishing Service, 1990.
21. Torvaldsen S, Hull BP, McIntyre PB. Using the Australian Childhood Immunisation Register to track the transition from whole-cell to acellular vaccines. Commun Dis Intell 2002;26:581-3.
22. Skowronski DM, De Serres G, MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002;185:1448-53.
23. Salmaso S, Mastrantonio P, Tozzi AE, et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001;108:E81.
24. Poynten M, Hanlon M, Irwig L, Gilbert GL. Serological diagnosis of pertussis: evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection. Epidemiol Infect 2002;128:161-7.
25. Torvaldsen S. The epidemiology and prevention of pertussis in Australia. Ph.D. Dissertation, Department of Paediatrics and Child Health. Sydney: University of Sydney, 2001.